News & Updates
DRG is proud to announce the launch of two new Anti-Müllerian Hormone (AMH) assays: AMH ELISA (EIA-6141) AMH DRG HYBRiD XL® (HYE-5770) Clinical Application: AMH has been identified as a reliable marker of ovarian reserve that can help predict early ovarian...
The growth and further development of the North American market is a key priority for us and the sole focus of the new Sales and Business Development Executive we are looking to recruit.
On April 30th, 2020, an organized study by Radboud University Medical Center in Nijmegen, Netherlands, has completed a final report for the DRG International’s first ever Hepcidin Proficiency Test.
The Stifterverband für die Deutsche Wissenschaft honors the research activities of DRG Instruments GmbH with the “Innovative Through Research” seal of approval…
The median of Hepcidin 25 serum concentration was markedly elevated in the De Quervain thyroiditis patients in comparison to control subjects and decreased significantly after therapy.
Regional forum of laboratory medicine (expo)
Yuzho-Sakhalinsk , Russia
Symposium Klinicke Biochemie FONS 2020
Pardubice, Czech Republick